Work

Abstract 5650: Preclinical development of LUA006: A bispecific EGFR/B7-H3 ADC with dual payloads to address tumor heterogeneity and resistance.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-5650

Authors: Shaojuan Zhao, Ling Zhang, Ying Huang, Qian Dong, Xiaofan Gu, Guoshun Tian, Xiaoman Li, Fanrui Meng, Wei Zheng, Xiaoshuang Yan, Xinmei Wang, Yazhi Yuan, Shuyong Zhao, Ken Qin, Yang Yang, Hua Ying, Weikang Tao

Institution: Qilu Pharmaceutical Co., Ltd. (China)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148766046

Cites:

Cited by:

Related to: